https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2025-08-19 / Front Immunol 2025;16:1633100
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2025-08-19 / Front Immunol 2025;16:16331002025-08-19 00:00:002025-08-19 00:00:00Mechanisms and clinical advancements of cell-based immunotherapies in non-small cell lung cancer: an integrated perspective
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-10-28 / Mol Ther Oncol 2024 Dec;32(4):200899
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-10-28 / Mol Ther Oncol 2024 Dec;32(4):2008992024-10-28 00:00:002024-10-28 00:00:00IL-12 encoding oNDV synergizes with CAR-T cells in orthotopic models of non-small cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-09-13 / Oncol Lett 2024 Nov;28(5):550
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-09-13 / Oncol Lett 2024 Nov;28(5):5502024-09-13 00:00:002024-09-13 00:00:00induction of anti‑lung cancer immune response by the A549 lung cancer stem cell lysate‑sensitized dendritic cell vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-09-06 / Front Immunol 2024;15:1376704
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-09-06 / Front Immunol 2024;15:13767042024-09-06 00:00:002025-09-04 16:45:39Dendritic cell-based immunotherapy in non-small cell lung cancer: a comprehensive critical review
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-04-15 / Cell Rep Med 2024 May;5(5):101516
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-04-15 / Cell Rep Med 2024 May;5(5):1015162024-04-15 00:00:002025-09-04 16:58:25Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-02-10 / J Med Case Rep 2024 Feb;18(1):88
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-02-10 / J Med Case Rep 2024 Feb;18(1):882024-02-10 00:00:002024-02-10 00:00:00Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-11-06 / Cureus 2023 Nov;15(11):e48412
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-11-06 / Cureus 2023 Nov;15(11):e484122023-11-06 00:00:002023-11-06 00:00:00Radioimmunotherapy With WT1 Dendritic Cell Vaccine for End-Stage Lung Adenocarcinoma Markedly Shrinks Tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-11-01 / Immun Inflamm Dis 2023 Nov;11(11):e1099
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-11-01 / Immun Inflamm Dis 2023 Nov;11(11):e10992023-11-01 00:00:002025-09-04 17:02:01The DC-T cell axis is an effective target for the treatment of non-small cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-10-19 / Cureus 2023 Oct;15(10):e47320
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-10-19 / Cureus 2023 Oct;15(10):e473202023-10-19 00:00:002023-10-19 00:00:00WT1 Dendritic Cell Vaccine Therapy Improves Immune Profile and Prolongs Progression-Free Survival in End-Stage Lung Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-10-04 / Cells 2023 Oct;12(19)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-10-04 / Cells 2023 Oct;12(19)2023-10-04 00:00:002023-10-04 00:00:00Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment
